Provided herein are nanofibers and processes of preparing nanofibers. In some instances, the nanofibers are metal and/or ceramic nanofibers. In some embodiments, the nanofibers are high quality, high performance nanofibers, highly coherent nanofibers, highly continuous nanofibers, or the like. In some embodiments, the nanofibers have increased coherence, increased length, few voids and/or defects, and/or other advantageous characteristics. In some instances, the nanofibers are produced by electrospinning a fluid stock having a high loading of nanofiber precursor in the fluid stock. In some instances, the fluid stock comprises well mixed and/or uniformly distributed precursor in the fluid stock. In some instances, the fluid stock is converted into a nanofiber comprising few voids, few defects, long or tunable length, and the like.

The invention pertains to the technical field of urethane based materials, in particular to radiation curable urethane precursors that are cross-linkable in solid form and materials obtainable therefrom. In addition the invention pertains to methods for manufacturing these precursors and materials, and their uses. The invention is advantageous to the fields of i.e. coatings and biomedical applications.

A handheld portable electrostatic device for electrostatically applying a treatment solution to a treatment site of a patient, including a housing and a cartridge removably disposed in the housing. The cartridge includes a cartridge housing and a nozzle for applying the treatment solution. An electrostatic module is provided to electrostatically charge and ionize molecules of the treatment solution of the cartridge. The treatment solution is configured to flow toward the nozzle whereby at least one electrode electrically connected to the electrostatic module physically contacts the treatment solution as it flows therethrough and applies an electrical charge to the treatment solution.

A carbon nanowire contains a photocatalytic metal-organic framework (MOF) in the form of a nanoparticle. Methods herein may produce a nanowire, fabrics, nonwoven fabrics, products, etc. containing such a nanowire, and/or the MOF having antibacterial and/or pathogenic efficacy upon irradiation.

An applicator is disclosed for applying a treatment solution to a treatment site of a patient. The applicator can include an applicator housing comprising a treatment solution reservoir. A cartridge can be removably disposed in the housing. The cartridge when arranged in the housing can be in fluid communication with the treatment solution reservoir. The cartridge can include an electrostatic module for electrostatically charging the treatment solution in the treatment solution reservoir; and a nozzle for applying the treatment solution.

A method for producing a nonwoven for shielding electromagnetic radiation in a terahertz (THz) range includes: providing a first metal alloy adapted to shield electromagnetic radiation; providing a polymer material; providing a second metal alloy which differs from the first metal alloy; producing polymer fibers with filled fiber cores by evaporating the first metal alloy and mixing the first metal alloy molecules with the polymer material; coating at least a part of a surface of the polymer fibers with the second metal alloy; producing the nonwoven by randomly and irregularly arranging the coated polymer fibers with filled fiber cores in a three spatial dimensional directions, or producing the nonwoven by randomly and irregularly arranging the polymer fibers with filled fiber cores in the three spatial dimensional directions and coating at least a part of a surface of the nonwoven with the second metal alloy.

A biodegradable cardiovascular implant is provided for growing cardiovascular tissue in a patient. The implant distinguishes an electro-spun network with supramolecular compounds having hard-blocks covalently bonded with soft-blocks resulting in much enhanced durability and fatigue resistance, while maintaining the effectiveness as a cardiovascular implant.

Lithium-containing nanofibers, as well as processes for making the same, are disclosed herein. In some embodiments described herein, using high throughput (e.g., gas assisted and/or water based) electrospinning processes produce nanofibers of high energy capacity materials with continuous lithium-containing matrices or discrete crystal domains.

Disclosed herein is a novel polymer having a structure based on a biodegradable polymer. In the novel polymer, the biodegradable polymer has at least one kind of functional groups from among a hydroxyl group and a carboxyl group, wherein the biodegradable polymer bears a functional group conjugated with a nitric oxide-releasing compound and a different functional group substituted with a photopolymerizable functional group, the nitric oxide-releasing compound comprising a NO donor. Also provided is a nanofiber fabricated from the modified biodegradable polymer. The nanofiber can be fabricated by electrospinning the novel polymer.

Disclosed is a medical material manufactured using collagen and a method of manufacturing the same. The method includes (1) preparing collagen using distilled water as a solvent, (2) filling a syringe with the prepared collagen and then spinning the collagen through a syringe needle, (3) immediately immersing the spun collagen in a cross-linking solution, which is a mixture including therein a hyperosmotic agent and a cross-linking agent mixed with each other, (4) removing and then washing the collagen after cross-linking is completed, and (5) removing and then drying the collagen after the washing is completed. When the collagen is spun and processed into the form of a thread and the spun thread is then cross-linked, the cross-linked collagen thread has increased strength compared to before cross-linking, and the shape thereof is retained in an aqueous solution.